Advances in Nano-Functional Materials in Targeted Thrombolytic Drug Delivery

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Thrombotic disease is a leading cause of vascular mortality worldwide.
• Current thrombolytic drugs often cause adverse bleeding events.
• Nanotechnology offers potential for targeted drug delivery to reduce these risks.

Purpose of the Study:

• To review the progress of nanomaterials in targeted thrombolytic drug delivery.
• To explore the use of external stimuli-responsive nanomaterials for enhanced thrombolysis.
• To discuss the application of organic, inorganic, and biomimetic nanomaterials in this field.

Main Methods:

• Review of existing literature on nanomaterial-based thrombolysis.
• Analysis of studies utilizing external stimuli (magnetic, light, ultrasound) for drug enrichment.
• Categorization of nanomaterials into organic, inorganic, and biomimetic types.

Main Results:

• Nanomaterials can effectively enrich thrombolytic drugs at the clot site.
• Stimuli-responsive nanomaterials improve drug concentration and thrombolysis efficacy.
• Various nanomaterial types show collaborative thrombolytic potential.

Conclusions:

• Nanomaterial-based drug delivery systems represent a significant advancement in treating thrombotic diseases.
• Targeted delivery and external stimuli significantly improve therapeutic outcomes and safety profiles.
• Further research into organic, inorganic, and biomimetic nanomaterials is crucial for clinical translation.